Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin

Area of Science:

• Microbiology
• Pharmacology
• Antibiotic Resistance

Background:

• Rosamicin is a new macrolide antibiotic derived from Micromonospora rosaria.
• It exhibits similarities to erythromycin in chemical and biological properties.

Purpose of the Study:

• To evaluate the in vitro activity of rosamicin against various bacterial strains.
• To compare rosamicin's efficacy with erythromycin and lincomycin, focusing on gram-positive and gram-negative organisms.

Main Methods:

• Broth dilution assays were employed to determine the minimum inhibitory concentrations (MICs).
• Activity was assessed against Staphylococcus aureus, Staphylococcus epidermidis, enterococci, viridans streptococci, group A streptococci, Enterobacteriaceae, and Pseudomonas.
• Comparative analysis with erythromycin and lincomycin was performed under varying pH conditions.

Main Results:

• Rosamicin demonstrated bacteriostatic activity against most tested gram-positive strains at concentrations of 0.02 to 4.0 µg/ml.
• Erythromycin and lincomycin showed similar results, with exceptions for enterococci.
• Incomplete cross-resistance was observed between rosamicin, erythromycin, and lincomycin.
• Rosamicin exhibited superior activity against Enterobacteriaceae and Pseudomonas compared to erythromycin, particularly at alkaline pH (7.6 and 8.0).

Conclusions:

• Rosamicin possesses significant in vitro activity against gram-positive bacteria.
• The antibiotic displays enhanced efficacy against gram-negative organisms compared to erythromycin.
• The lack of complete cross-resistance suggests potential for overcoming existing resistance mechanisms.
• Further investigation of rosamicin as a therapeutic agent is warranted.